Patent · US Active

Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors

US7767687B2 · kind B2 · utility

23Cited by
3References
60Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 12, 2005
Grant dateAug 3, 2010
Priority date
Expiry dateJan 26, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds having the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.